Bragar Eagel & Squire, P.C. Is Investigating USANA Health Sciences, Inc. (USNA) on Behalf of Stockholders and Encourages Investors to Contact the Firm

09-Feb-2017 Intellasia | BusinessWire | 5:30 AM Print This Post

NEW YORK–(BUSINESS WIRE)–Bragar Eagel & Squire, P.C. is investigating potential claims against
USANA Health Sciences, Inc. (NYSE:USNA) concerning possible violations
of the federal securities laws.

On February 7, 2017, post-market, USANA disclosed that the Company is
“voluntarily conducting an internal investigation of its China
operations, BabyCare Ltd. The investigation focuses on compliance with
the Foreign Corrupt Practices Act . . . and certain conduct and policies
at BabyCare, including BabyCare’s expense reimbursement policies.”

Following this news, USANA shares declined $7.25 per share, or over
11.5%, on February 8, 2017 to close at $55.40.

If you purchased or otherwise acquired USANA securities and suffered a
loss, have information, would like to learn more about these claims, or
have any questions concerning this announcement or your rights or
interests with respect to these matters, please contact J. Brandon
Walker, Esq. by email at [email protected],
or telephone at (212) 355-4648, or by filling
out this contact form
. There is no cost or obligation to you.

Bragar Eagel & Squire, P.C. is a New York-based law firm concentrating
in commercial and securities litigation. For additional information
concerning our investigation into USANA, please go to
For additional information about Bragar Eagel & Squire, P.C., please go


Bragar Eagel & Squire, P.C.
J. Brandon Walker, Esq.,
[email protected]


Category: BusinessWire, PRAsia

Print This Post

Comments are closed.